Last week, Founder Rohit Kulkarni had the opportunity to discuss biological tech with Dr. Tyler Cowen, a professor, economist, and investor who teaches at George Mason University.

Rohit and Dr. Cowen spoke about the problems in pharmaceutical technology and the lengthy trial-and-error process of the field. They also discussed the field of AI and how it can revolutionize drug discovery.

BioMolecular is pleased to announce that it has been backed by an angel investment from Dr. Cowen to conduct research and develop tech to save lives. We are excited to use this money to build the future of drug discovery.